DARZALEX — Percent Change (as a percent)
Johnson & Johnson DARZALEX — Percent Change (as a percent) increased by 1630.8% to 22.5% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.8%, from 20.3% to 22.5%. Over 2 years (FY 2023 to FY 2025), DARZALEX — Percent Change (as a percent) shows relatively stable performance with a 0.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests accelerating market adoption or expanded clinical indications, whereas a decrease may indicate market saturation or the emergence of competitive therapies.
Detailed definition
This metric measures the period-over-period percentage growth rate of net sales for a specific pharmaceutical product. I...
Peer comparison
Comparable to year-over-year or sequential growth rates for key product lines reported by peers in the biopharmaceutical industry.
jnj_segment_darzalex_percent_change_as_a_percentHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 59.2% | 43.7% | 36% | 38.6% | 29.8% | 22% | 22.4% | 21.8% | 0.1% | 18.9% | 18.4% | 20.7% | 0.5% | 20.3% | 23% | 21.7% | 1.3% | 22.5% |
| QoQ Change | — | -26.2% | -17.6% | +7.2% | -22.8% | -26.2% | +1.8% | -2.7% | -99.5% | >999% | -2.6% | +12.5% | -97.6% | >999% | +13.3% | -5.7% | -94.0% | >999% |
| YoY Change | — | — | — | -34.8% | -31.8% | -38.9% | -42.0% | -26.8% | — | -14.1% | -17.9% | -5.0% | +400.0% | +7.4% | +25.0% | +4.8% | +160.0% | +10.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's darzalex — percent change (as a percent)?
- Johnson & Johnson (JNJ) reported darzalex — percent change (as a percent) of 22.5% in Q1 2026.
- How has Johnson & Johnson's darzalex — percent change (as a percent) changed year-over-year?
- Johnson & Johnson's darzalex — percent change (as a percent) increased by 10.8% year-over-year, from 20.3% to 22.5%.
- What is the long-term trend for Johnson & Johnson's darzalex — percent change (as a percent)?
- Over 2 years (2023 to 2025), Johnson & Johnson's darzalex — percent change (as a percent) has grown at a 0.0% compound annual growth rate (CAGR), from 66.3% to 66.3%.
- What does darzalex — percent change (as a percent) mean?
- The percentage growth rate of sales for a specific drug compared to a prior period.